The medical tech company is about to join the S&P SmallCap 600 index. While this doesn't change the fundamental investing thesis for the stock, it does make it a target of the many index funds on the ...
Waystar Holding Corp. is rated buy, with an 85% upside to a $37 price target, as current share price reflects temporary private equity (PE) selling pressure, not business fundamentals. Waystar's ...
Hosted on MSN
What Makes Waystar (WAY) a New Buy Stock
Waystar Holding (WAY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates - ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Waystar provides a cloud-based software platform focused on healthcare payments, including financial clearance, patient financial care, claims and payment management, denial prevention and recovery, ...
The new position in Waystar accounts for 6.4% of Capricorn Fund Managers' 13F reportable assets under management. The stock is now the fund’s largest holding by reported market value. The fund's top ...
Waystar’s share price has gone quiet, but Wall Street still sees upside. Is this healthcare-payments platform a sleeper opportunity or a value trap for US investors waiting on profitable growth?
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
For stock investors, one way to prosperity on Monday was by having a position in medical tech company Waystar (NASDAQ: WAY). After all, it was an outlier in the best way possible, since it shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results